FIELD: pharmacology.
SUBSTANCE: pharmaceutical composition is described, comprising [18F]-FACBC (1-amino-3-[18F]-ftorciklobutan-1-carboxylic acid), a citrate buffer, 1-amino-3-gidroxiciklobutan-1-carboxylic acid and has pH of 4.0-5.0. Also the method for preparing the composition is described.
EFFECT: composition is resistant to degradation.
18 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF RADIOACTIVE LABELING | 2014 |
|
RU2675371C2 |
| PRODUCTION OF F-FLUCYCLOWINE | 2013 |
|
RU2640805C2 |
| ELUENT SOLUTION | 2011 |
|
RU2608932C2 |
| PRODUCTION OF PET PRECURSOR | 2011 |
|
RU2587308C2 |
| METHOD FOR RADIO-LABELING | 2014 |
|
RU2690848C2 |
| STABILISATION OF RADIOPHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2474435C2 |
| CLOSED EVAPORATION SYSTEM | 2014 |
|
RU2673797C2 |
| PEPTIDE COMPOSITION OF RADIOACTIVE INDICATORS | 2011 |
|
RU2594167C2 |
| RADIOPHARMACEUTICAL COMPOSITION | 2008 |
|
RU2475267C2 |
| CLEANING PRECURSOR COMPOUND BY CRYSTALLISATION | 2011 |
|
RU2586881C2 |
Authors
Dates
2017-06-22—Published
2012-12-21—Filed